There is an enhanced inflammation seen in patients with CGD, with a mechanism not fully understood but likely related to a defective production of ROS leading to increased expression of NFkB-regulated inflammatory genes [17] and high levels of inflammatory mediators that are expressed in monocytes from patients with X-linked CGD without acute infection compared with controls. This evidence concerns the gene NFKB1 and chronic granulomatous disease.